scholarly journals Optimizing blood pressure control and renal protection with angiotensin II receptor blockers

2003 ◽  
Vol 16 (5) ◽  
pp. A267
Author(s):  
M POHL
Keyword(s):  
Blood Pressure ◽  
Angiotensin Ii ◽  
Blood Pressure Control ◽  
Pressure Control ◽  
Angiotensin Ii Receptor Blockers ◽  
Angiotensin Ii Receptor ◽  
Renal Protection ◽  
Receptor Blockers

scholarly journals Valsartan: come versatilità e tollerabilità possono contribuireal contenimento della spesa sanitaria

2011 ◽  
Vol 12 (1S) ◽  
pp. 9-17
Author(s):  
Francesco Vittorio Costa
Keyword(s):  
Blood Pressure ◽  
Angiotensin Ii ◽  
Cardiovascular Disorder ◽  
Angiotensin Ii Receptor Blockers ◽  
Efficacy And Safety ◽  
Angiotensin Ii Receptor ◽  
Renal Protection ◽  
Receptor Blockers ◽  
Blood Pressure Goals

The search for a more specific and complete blockade of the hypertensive effects of angiotensin and of better tolerability than ACE-inhibitors has led to the development of angiotensin II receptor blockers (ARBs). ARBs have been evaluated in several large studies in terms of efficacy and safety in reducing blood pressure, as well as for cardiovascular and renal protection. Among angiotensin II receptor blockers, valsartan and losartan have the greatest number of therapeutic indications. In light of the costs related to cardiovascular disorder valsartan represents a potential long-term health cost saving strategy. Furthermore valsartan shows one of the lowest costs for patient achieving blood pressure goals and the higher level of persistence in its class.

Sign in / Sign up

Export Citation Format

Share Document